Navigation Links
Research leads to better understanding of peripheral neuropathy
Date:3/5/2013

One in 25,000 people worldwide is affected by neurofibromatosis type 2 (NF2), a condition where the loss of a tumour suppressor called Merlin results in multiple tumours in the brain and nervous system.

Sufferers may experience 20 to 30 tumours at any one time and such numbers often lead to hearing loss, disability and eventually death. Those with NF2 may also experience peripheral neuropathy, which is when the nerves carrying messages to and from the brain and spinal column to the rest of the body do not work.

Peripheral neuropathy leads to further complications for NF2 sufferers, such as pain and numbness, muscle problems, problems with body organs and other symptoms of nerve damage, such as bladder problems, uncontrollable sweating and sexual dysfunction.

Researchers from Plymouth University Peninsula Schools of Medicine and Dentistry are part of an international research team which has for the first time identified the role of a tumour suppressor called Merlin in regulating the integrity of axons. Axons are nerve fibres which transmit information around the body and it is these are that damaged in peripheral neuropathy.

The research team showed that Merlin regulates a protein called neurofilament which supplies structural support for the axon.

A better understanding of this mechanism could lead to effective drug therapies to alleviate the symptoms of peripheral neuropathy in patients with NF2.

The results of the research is published this week in Nature Neuroscience.


'/>"/>

Contact: Andrew Gould
andrew.gould@pcmd.ac.uk
44-188-438-346
University of Plymouth
Source:Eurekalert

Page: 1

Related medicine news :

1. U of M researchers find wide variation in cesarean delivery rates among US hospitals
2. New Center for Open Science designed to increase research transparency
3. BUSM researchers use goal-oriented therapy to treat diabetic neuropathies
4. Researchers Describe 1st Functional Cure of HIV in Baby
5. Research Finds Use of Volpara Objective Breast Density Software from Matakina Helps Overcome the Limitations of Mammography for Women with Dense Breasts
6. Pediatric cancer charities partner to fund international collaborative research
7. Industry and academic researchers gather for innovative accelerating cancer cures research symposium
8. Researchers describe first functional HIV cure in an infant
9. Researchers discover how to shutdown cancers powerful master protein
10. Research and Markets - Drug Delivery in Cancer - Technologies, Markets and Companies - 2013 Report
11. Research: Brain cant cope with making a left-hand turn and talking on hands-free cell phone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... Chicago, IL (PRWEB) , ... September 21, 2017 , ... ... set to run from September 11 to the end of November. , The Chicago, ... out to their community and teach them about the ease of taking their personal ...
(Date:9/21/2017)... ... 2017 , ... Demonstrating a consistent and continued commitment to ... awarded five-year accreditation status through the Public Health Accreditation Board (PHAB). ... a PHAB-accredited health department now extend to more than 203 million people, or ...
(Date:9/21/2017)... ... , ... The New England Center for Children® (NECC®), a global leader in ... to the Board of Directors. , “The New England Center for Children is ... invaluable addition to our team,” said Vincent Strully, Jr., President and CEO of The ...
(Date:9/21/2017)... ... September 21, 2017 , ... FlipBelt, the fitness brand that ... detail to the athletic wear market with the launch of their FlipBelt Crops. , ... their essentials securely at their fingertips while at the gym, on the trail, or ...
(Date:9/20/2017)... Prescott, AZ (PRWEB) , ... September 20, 2017 ... ... addiction treatment center in Prescott, Arizona, is now accredited by The Joint Commission ... independent, nonprofit organization that accredits and certifies U.S. health care organizations that meet ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017   PDI , a leader ... will host an educational session focused on the role ... (CLABSI) prevention at the 2017 Annual Scientific Meeting of ... take place at the Phoenix ... from Sept. 16-19, will also feature PDI,s Prevantics® ...
(Date:9/6/2017)... Eli Lilly and Company (NYSE: LLY ) ... and lasmiditan, two investigational treatments for migraine, at the ... place Sept. 7-10 in Vancouver . ... from an open-label study evaluating the safety and effectiveness ... mg) for the prevention of migraine. Galcanezumab is a ...
(Date:9/5/2017)... , Sept. 5, 2017  Xyntek Inc. has announced another milestone in their ... Midwest office to meet the growing demands of customer engagements regionally.  ... Xyntek's new Midwest office is located at 318 West Adams ... ... engagements regionally. ...
Breaking Medicine Technology: